2022
DOI: 10.1038/s41584-022-00820-5
|View full text |Cite
|
Sign up to set email alerts
|

Kawasaki disease and MIS-C share a host immune response

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
8
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 7 publications
0
8
0
Order By: Relevance
“…A recent study using artificial intelligence to compare the gene expression signatures of KD and MIS-C suggested that the profiles of host immune responses in KD and MIS-C patients are similar [ 14 ]. It is hypothesized that KD and MIS-C are not different diseases but have overlapping features reflecting different parts of the disease spectrum [ 15 ].…”
Section: Discussionmentioning
confidence: 99%
“…A recent study using artificial intelligence to compare the gene expression signatures of KD and MIS-C suggested that the profiles of host immune responses in KD and MIS-C patients are similar [ 14 ]. It is hypothesized that KD and MIS-C are not different diseases but have overlapping features reflecting different parts of the disease spectrum [ 15 ].…”
Section: Discussionmentioning
confidence: 99%
“…Most patients with MIS-C show KD-related features, gastrointestinal problems, and hypotension, as did our two patients in this study. The presence of KD-related features in patients with MIS-C has received clinical attention, but the extent of organ dysfunction in patients with MIS-C is of greater importance as it directly affects the disease course and outcome [ 4 , 13 ]. In children and in adults, MIS can occur as a serious post-infectious complication of COVID-19.…”
Section: Discussionmentioning
confidence: 99%
“…In the future, we hope to find more extensive and accurate gene features in existing studies (related to cytokines, cellular immunophenotypes, antibodies, gene susceptibility, etc. ), use artificial intelligence algorithms to define and layer diseases from clinical or laboratory parameters, and identify the phenotypes and complications of disease spectrum, including cardiogenic shock (such as MIS-C shock and Kawasaki disease shock syndrome), MAS (cytopenia and coagulation dysfunction related to cytokine storm caused by infection), Kawasaki disease (typical and complete Kawasaki disease phenotype, caused by SARS -CoV-2 or other infectious factors), and provide evidence for the formulation of treatment strategies [10]. In the future, the amount of research data should be further expanded in clinical practice, and the special method of artificial intelligence should be used to diagnose, differential diagnosis and treatment of the above diseases to serve the clinical.…”
Section: Discussionmentioning
confidence: 99%